Daiken Medical Co

Daiken Medical Co EBIT

The EBIT of Daiken Medical Co (7775.T) as of Nov 13, 2026 is 1.28 B JPY. In the previous year, EBIT was 1.51 B JPY — a change of -15.51% (lower).

EBIT

1.28 BJPY

YoY

-15.51%

Last updated:

In 2026, Daiken Medical Co's EBIT was 1.28 B JPY, a -15.51% increase from the 1.51 B JPY EBIT recorded in the previous year.

The Daiken Medical Co EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2022
1.16 B JPY
Jan 1, 2023
1.05 B JPY
Jan 1, 2024
1.44 B JPY
Jan 1, 2025
1.51 B JPY
Jan 1, 2026
1.28 B JPY
Jan 1, 2027 (e)
933.55 M JPY
Jan 1, 2028 (e)
917.46 M JPY
Jan 1, 2029 (e)
945.61 M JPY
The Daiken Medical Co EBIT history
YEAREBITYoY
est945.61 MJPY+3.07%
est917.46 MJPY-1.72%
est933.55 MJPY-26.93%
1.28 BJPY-15.51%
1.51 BJPY+4.81%
1.44 BJPY+36.81%
1.05 BJPY-8.71%
1.16 BJPY+21.77%
948.56 MJPY-20.58%
1.19 BJPY-4.42%
1.25 BJPY-17.01%
1.51 BJPY-12.01%
1.71 BJPY+0.90%
1.70 BJPY+4.57%
1.62 BJPY+16.69%
1.39 BJPY+10.24%
1.26 BJPY+24.26%
1.01 BJPY+4.13%
974.35 MJPY+16.63%
835.43 MJPY+18.11%
707.34 MJPY+33.79%
528.70 MJPY+18.12%
447.60 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Daiken Medical Co Revenue

Daiken Medical Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
8.54 B JPY
1.16 B JPY
831.06 M JPY
Jan 1, 2023
9.14 B JPY
1.05 B JPY
712.06 M JPY
Jan 1, 2024
9.75 B JPY
1.44 B JPY
988.60 M JPY
Jan 1, 2025
9.95 B JPY
1.51 B JPY
1.10 B JPY
Jan 1, 2026
10.29 B JPY
1.28 B JPY
922.64 M JPY
Jan 1, 2027 (e)
10.35 B JPY
933.55 M JPY
732.32 M JPY
Jan 1, 2028 (e)
10.75 B JPY
917.46 M JPY
719.58 M JPY
Jan 1, 2029 (e)
11.20 B JPY
945.61 M JPY
741.87 M JPY

Daiken Medical Co Margins

Daiken Medical Co stock margins

The Daiken Medical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Daiken Medical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Daiken Medical Co.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
43.14 %
13.52 %
9.73 %
Jan 1, 2023
38.64 %
11.54 %
7.79 %
Jan 1, 2024
40.84 %
14.80 %
10.14 %
Jan 1, 2025
41.17 %
15.19 %
11.03 %
Jan 1, 2026
38.40 %
12.41 %
8.97 %
Jan 1, 2027 (e)
38.40 %
9.02 %
7.08 %
Jan 1, 2028 (e)
38.40 %
8.53 %
6.69 %
Jan 1, 2029 (e)
38.40 %
8.44 %
6.62 %

Daiken Medical Co Stock analysis

What does Daiken Medical Co do? Daiken Medical Co., Ltd. generates revenue through the sale of anesthesia and infection control products, including the Fit Fix suction container system, Coopdech QinPot, syrinjector, balloonjector, patient control analgesia (PCA) devices, pressure infusion instruments, syringe pumps, infusion pumps, SteriKeep II, Wipell, bronchial blocker tube, and breath warm. The company targets healthcare facilities and medical institutions that require specialized equipment for anesthesia administration and infection prevention. Its product portfolio is structured into five distinct categories, each addressing specific clinical needs within operating rooms and patient care environments. Revenue streams are derived from direct sales of these medical devices to hospitals and clinics across Japan and potentially international markets. The company's suction device products, such as the Fit Fix suction container system and Coopdech QinPot, cater to procedures requiring efficient fluid management. Syrinjector-related items like the syrinjector and PCA devices support pain management and controlled drug delivery. Electric pump products, including syringe pumps and infusion pumps, are essential for precise medication administration. Medical hand washing machines like SteriKeep II and Wipell are designed for infection control protocols, while other products such as bronchial blocker tubes and breath warm devices serve niche surgical applications. All products are sold directly to healthcare providers without third-party intermediaries. Daiken Medical Co., Ltd. focuses on delivering specialized medical equipment that addresses critical needs in anesthesia and infection control. Its product groups are tailored to meet the operational requirements of hospitals and clinics, ensuring compliance with medical standards. The company’s revenue model relies on consistent demand for these high-precision devices, with no indication of additional services or subscription-based offerings in its business description. Daiken Medical Co is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Daiken Medical Co's EBIT

Daiken Medical Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Daiken Medical Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Daiken Medical Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Daiken Medical Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Daiken Medical Co stock

EBIT of Daiken Medical Co is 1.28 B JPY in 2026.

EBIT of Daiken Medical Co changed from 1.51 B JPY to 1.28 B JPY, representing a -15.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Daiken Medical Co since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Daiken Medical Co historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Daiken Medical Co

All Key Metrics — Daiken Medical Co